756
Views
45
CrossRef citations to date
0
Altmetric
Theme: Epilepsy - Review

Etiologies of epilepsy: a comprehensive review

, , &
Pages 861-876 | Published online: 09 Jan 2014

References

  • Preux PM, Druet-Cabanac M. Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurol.4(1), 21–31 (2005).
  • Mac TL, Tran DS, Quet F, Odermatt P, Preux PM, Tan CT. Epidemiology, aetiology, and clinical management of epilepsy in Asia: a systematic review Lancet Neurol.6(6), 533–543 (2007).
  • Burneo JG, Tellez-Zenteno J, Wiebe S. Understanding the burden of epilepsy in Latin America: a systematic review of its prevalence and incidence. Epilepsy Res.66(1–3), 63–74 (2005).
  • Johnson MR, Sander JW. The clinical impact of epilepsy genetics. J. Neurol. Neurosurg. Psychiatry70(4), 428–430 (2001).
  • Lopes-Cendes I. The genetics of epilepsies. J. Pediatr. (Rio J.)84(4 Suppl.), S33–S39 (2008).
  • Gourfinkel-An I. [Genetic aspects of epilepsy]. EMC Neurologie160(17), 1–14 (2009).
  • Engel J.Epilepsy, A Comprehensive Textbook. Lippincott Williams & Williams, PA, USA (2008).
  • Galvan-Manso M, Campistol J, Conill J, Sanmarti FX. Analysis of the characteristics of epilepsy in 37 patients with the molecular diagnosis of Angelman syndrome. Epileptic Disord.7(1), 19–25 (2005).
  • Sorge G, Sorge A. Epilepsy and chromosomal abnormalities. Ital. J. Pediatr.36, 36 (2010).
  • Liigant A, Haldre S, Oun A et al. Seizure disorders in patients with brain tumors. Eur. Neurol.45(1), 46–51 (2001).
  • van Breemen MS, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol.6(5), 421–430 (2007).
  • Mangano FT MA, Schneider SJ. Brain tumors and epilepsy. In: Managing Epilepsy and Co-existing Disorders. Butterworth-Heinemann, MA, USA, 175–194 (2002).
  • Luyken C, Blumcke I, Fimmers R et al. The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia44(6), 822–830 (2003).
  • Sperling MR, Ko J. Seizures and brain tumors. Semin. Oncol.33(3), 333–341 (2006).
  • Lote K, Stenwig AE, Skullerud K, Hirschberg H. Prevalence and prognostic significance of epilepsy in patients with gliomas. Eur. J. Cancer34(1), 98–102 (1998).
  • Vecht CJ, van Breemen M. Optimizing therapy of seizures in patients with brain tumors. Neurology67(12 Suppl. 4), S10–S13 (2006).
  • Kim OJ, Yong Ahn J, Chung YS et al. Significance of chronic epilepsy in glial tumors and correlation with surgical strategies. J. Clin. Neurosci.11(7), 702–705 (2004).
  • Ivens S, Kaufer D, Flores LP et al. TGF-β receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain130(Pt 2), 535–547 (2007).
  • Rajneesh KF, Binder DK. Tumor-associated epilepsy. Neurosurg. Focus27(2), E4 (2009).
  • Shamji MF, Fric-Shamji EC, Benoit BG. Brain tumors and epilepsy: pathophysiology of peritumoral changes. Neurosurg. Rev.32(3), 275–284; discussion 284–276 (2009).
  • Maas S, Patt S, Schrey M, Rich A. Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc. Natl Acad. Sci. USA98(25), 14687–14692 (2001).
  • Kang TC, An SJ, Park SK, Hwang IK, Bae JC, Won MH. Changed vesicular GABA transporter immunoreactivity in the gerbil hippocampus following spontaneous seizure and vigabatrin administration. Neurosci. Lett.335(3), 207–211 (2003).
  • Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984. Epilepsia34(3), 453–468 (1993).
  • Lowenstein DH. Epilepsy after head injury: an overview. Epilepsia50(Suppl. 2), 4–9 (2009).
  • Christensen J, Pedersen MG, Pedersen CB, Sidenius P, Olsen J, Vestergaard M. Long-term risk of epilepsy after traumatic brain injury in children and young adults: a population-based cohort study. Lancet373(9669), 1105–1110 (2009).
  • Raymont V, Salazar AM, Lipsky R, Goldman D, Tasick G, Grafman J. Correlates of posttraumatic epilepsy 35 years following combat brain injury. Neurology75(3), 224–229 (2010).
  • Agrawal A, Timothy J, Pandit L, Manju M. Post-traumatic epilepsy: an overview. Clin. Neurol. Neurosurg.108(5), 433–439 (2006).
  • Shorvon S. Handbook of Epilepsy Treatment. Blackwell Publishing, Oxford, UK (2010).
  • Shorvon S. Handbook of Epilepsy Treatment: Forms, Causes and Therapy in Children and Adults. Blackwell Publishing, Oxford, UK (2005).
  • Pomeroy SL, Holmes SJ, Dodge PR, Feigin RD. Seizures and other neurologic sequelae of bacterial meningitis in children. N. Engl. J. Med.323(24), 1651–1657 (1990).
  • Annegers JF, Hauser WA, Beghi E, Nicolosi A, Kurland LT. The risk of unprovoked seizures after encephalitis and meningitis. Neurology38(9), 1407–1410 (1988).
  • Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci.10(11), 1387–1394 (2007).
  • Galic MA, Riazi K, Heida JG et al. Postnatal inflammation increases seizure susceptibility in adult rats. J. Neurosci.28(27), 6904–6913 (2008).
  • Maroso M, Balosso S, Ravizza T et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat. Med.16(4), 413–419 (2010).
  • Karatas H, Gurer G, Pinar A et al. Investigation of HSV-1, HSV-2, CMV, HHV-6 and HHV-8 DNA by real-time PCR in surgical resection materials of epilepsy patients with mesial temporal lobe sclerosis. J. Neurol. Sci.264(1–2), 151–156 (2008).
  • Misra UK, Tan CT, Kalita J. Viral encephalitis and epilepsy. Epilepsia49(Suppl. 6), 13–18 (2008).
  • Misra UK, Kalita J. Seizures in encephalitis: predictors and outcome. Seizure18(8), 583–587 (2009).
  • Whitley R. Herpes simplex virus. In: Infections of the Central Nervous System. WM Scheld, RW, DT Durack (Eds). Lippincott-Raven, PA, USA, 73–89 (1997).
  • Yamada S, Kameyama T, Nagaya S, Hashizume Y, Yoshida M. Relapsing herpes simplex encephalitis: pathological confirmation of viral reactivation. J. Neurol. Neurosurg. Psychiatry74(2), 262–264 (2003).
  • Sanders VJ, Felisan SL, Waddell AE et al. Presence of herpes simplex DNA in surgical tissue from human epileptic seizure foci detected by polymerase chain reaction: preliminary study. Arch. Neurol.54(8), 954–960 (1997).
  • Wu HM, Huang CC, Chen SH et al. Herpes simplex virus type 1 inoculation enhances hippocampal excitability and seizure susceptibility in mice. Eur. J. Neurosci.18(12), 3294–3304 (2003).
  • Chuang MJ, Chang WN, Chang HW et al. Predictors and long-term outcome of seizures after bacterial brain abscess. J. Neurol. Neurosurg. Psychiatry81(8), 913–917 (2010).
  • Chadha DS, Handa A, Sharma SK, Varadarajulu P, Singh AP. Seizures in patients with human immunodeficiency virus infection. J. Assoc. Physicians India48(6), 573–576 (2000).
  • Fredj M, Mrabet H, Gouider R, Mrabet A. [Cerebral tuberculomas]. Revue Neurologique159(8–9), 795–798 (2003).
  • Ripamonti D, Barbo R, Rizzi M et al. New times for an old disease: intracranial mass lesions caused by Mycobacterium tuberculosis in 5 HIV-negative African immigrants. Clin. Infect. Dis.39(5), e35–e45 (2004).
  • Garcia HH, Gilman R, Martinez M et al. Cysticercosis as a major cause of epilepsy in Peru. The Cysticercosis Working Group in Peru (CWG). Lancet341(8839), 197–200 (1993).
  • Bern C, Garcia HH, Evans C et al. Magnitude of the disease burden from neurocysticercosis in a developing country. Clin. Infect. Dis.29(5), 1203–1209 (1999).
  • Del Brutto OH. [Neurocysticercosis: up-dating in diagnosis and treatment]. Neurologia20(8), 412–418 (2005).
  • Montano SM, Villaran MV, Ylquimiche L et al. Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology65(2), 229–233 (2005).
  • Nicoletti A, Bartoloni A, Sofia V et al. Epilepsy and neurocysticercosis in rural Bolivia: a population-based survey. Epilepsia46(7), 1127–1132 (2005).
  • Nsengiyumva G, Druet-Cabanac M, Ramanankandrasana B, Bouteille B, Nsizabira L, Preux PM. Cysticercosis as a major risk factor for epilepsy in Burundi, east Africa. Epilepsia44(7), 950–955 (2003).
  • Quet F, Guerchet M, Pion SD, Ngoungou EB, Nicoletti A, Preux PM. Meta-analysis of the association between cysticercosis and epilepsy in Africa. Epilepsia51(5), 830–837 (2010).
  • Carpio A, Hauser WA. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology59(11), 1730–1734 (2002).
  • Carpio A, WA Hauser. Neurocysticercosis and epilepsy. In: Taenia Solium Cysticercosis: from Basic to Clinical Science. Singh G, Prabhakar S (Eds). CABI Publishing, Oxford, UK, 211–220 (2002).
  • DeGiorgio CM, Medina MT, Duron R, Zee C, Escueta SP. Neurocysticercosis. Epilepsy Curr.4(3), 107–111 (2004).
  • Ngoungou EB, Preux PM. Cerebral malaria and epilepsy. Epilepsia49(Suppl. 6), 19–24 (2008).
  • Carter JA, Neville BG, White S et al. Increased prevalence of epilepsy associated with severe falciparum malaria in children. Epilepsia45(8), 978–981 (2004).
  • Versteeg AC CJ, Dzombo J, Neville BG, Newton CR. Seizure disorders among relatives of Kenyan children with severe falciparum malaria. Trop. Med. Int. Health8, 12–16. (2003).
  • Carter JA, Neville BG, Newton CR. Neuro-cognitive impairment following acquired central nervous system infections in childhood: a systematic review. Brain Res. Brain Res. Rev.43(1), 57–69 (2003).
  • Toro G, Roman G. Cerebral malaria. A disseminated vasculomyelinopathy. Arch. Neurol.35(5), 271–275 (1978).
  • Aleem MA. Epilepsy in malaria. Epilepsia46(4), 601; author reply 601–602 (2005).
  • Idro R, Marsh K, John CC, Newton CR. Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr. Res.68(4), 267–274 (2010).
  • Lang B, Newbold CI, Williams G, Peshu N, Marsh K, Newton CR. Antibodies to voltage-gated calcium channels in children with falciparum malaria. J. Infect. Dis.191(1), 117–121 (2005).
  • Pion SD, Kaiser C, Boutros-Toni F et al. Epilepsy in onchocerciasis endemic areas: systematic review and meta-analysis of population-based surveys. PLoS Negl. Trop. Dis.3(6), e461 (2009).
  • Boussinesq M, Pion SD, Demanga N, Kamgno J. Relationship between onchocerciasis and epilepsy: a matched case–control study in the Mbam Valley, Republic of Cameroon. Trans. R. Soc. Trop. Med. Hyg.96(5), 537–541 (2002).
  • Druet-Cabanac M, Boussinesq M, Dongmo L, Farnarier G, Bouteille B, Preux PM. Review of epidemiological studies searching for a relationship between onchocerciasis and epilepsy. Neuroepidemiology23(3), 144–149 (2004).
  • Druet-Cabanac M, Preux PM, Bouteille B et al. Onchocerciasis and epilepsy: a matched case–control study in the Central African Republic. Am. J. Epidemiol.149(6), 565–570 (1999).
  • Marin B, Boussinesq M, Druet-Cabanac M, Kamgno J, Bouteille B, Preux PM. Onchocerciasis-related epilepsy? Prospects at a time of uncertainty. Trends Parasitol.22(1), 17–20 (2006).
  • Duke BO, Vincelette J, Moore PJ. Microfilariae in the cerebrospinal fluid, and neurological complications, during treatment of onchocerciasis with diethylcarbamazine. Tropenmed. Parasitol.27(2), 123–132 (1976).
  • Soboslay PT, Dreweck CM, Taylor HR, Brotman B, Wenk P, Greene BM. Experimental onchocerciasis in chimpanzees. Cell-mediated immune responses, and production and effects of IL-1 and IL-2 with Onchocerca volvulus infection. J. Immunol.147(1), 346–353 (1991).
  • Wang S, Cheng Q, Malik S, Yang J. Interleukin-1β inhibits γ-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons. J. Pharmacol. Exp. Ther.292(2), 497–504 (2000).
  • Wang Y, Ruan X, Zhang S, Sun X. Effect of interleukin-1β on the elevation of cytoplasmic free calcium of the cultured hippocampal neurons induced by L-glutamate. J. Tongji Med. Univ.19(2), 120–123 (1999).
  • Kellinghaus C, Engbring C, Kovac S et al. Frequency of seizures and epilepsy in neurological HIV-infected patients. Seizure17(1), 27–33 (2008).
  • Yazar S, Arman F, Yalcin S, Demirtas F, Yaman O, Sahin I. Investigation of probable relationship between Toxoplasma gondii and cryptogenic epilepsy. Seizure12(2), 107–109 (2003).
  • Palmer BS. Meta-analysis of three case controlled studies and an ecological study into the link between cryptogenic epilepsy and chronic toxoplasmosis infection. Seizure16(8), 657–663 (2007).
  • da Silva RC, Langoni H. Toxoplasma gondii: host–parasite interaction and behavior manipulation. Parasitol. Res.105(4), 893–898 (2009).
  • Nicoletti A. Toxocariasis. Epilepsies22(2), 120–125 (2010).
  • Quet F, Nicoletti A, Preux PM. Comment on ‘Epilepsy and seropositivity rates of Toxocara canis and Toxoplasma gondii’. Seizure17(3), 296 (2007).
  • Bachli H, Minet JC, Gratzl O. Cerebral toxocariasis: a possible cause of epileptic seizure in children. Childs Nerv. Syst.20(7), 468–472 (2004).
  • Cleary P, Shorvon S, Tallis R. Late-onset seizures as a predictor of subsequent stroke. Lancet363(9416), 1184–1186 (2004).
  • Ryvlin P, Montavont A, Nighoghossian N. Optimizing therapy of seizures in stroke patients. Neurology67(12 Suppl. 4), S3–S9 (2006).
  • Olsen TS. Post-stroke epilepsy. Curr. Atheroscler. Rep.3(4), 340–344 (2001).
  • Bladin CF, Alexandrov AV, Bellavance A et al. Seizures after stroke: a prospective multicenter study. Arch. Neurol.57(11), 1617–1622 (2000).
  • Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C. Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. BMJ315(7122), 1582–1587 (1997).
  • Lamy C, Domigo V, Semah F et al. Early and late seizures after cryptogenic ischemic stroke in young adults. Neurology60(3), 400–404 (2003).
  • Kelly KM. Poststroke seizures and epilepsy: clinical studies and animal models. Epilepsy Curr.2(6), 173–177 (2002).
  • Nannucci S, Pescini F, Poggesi A et al. Familial cerebral cavernous malformation: report of a further Italian family. Neurol. Sci.30(2), 143–147 (2009).
  • Bertalanffy H, Benes L, Miyazawa T, Alberti O, Siegel AM, Sure U. Cerebral cavernomas in the adult. Review of the literature and analysis of 72 surgically treated patients. Neurosurg. Rev.25(1–2), 1–53; discussion 54–55 (2002).
  • Raychaudhuri R, Batjer HH, Awad IA. Intracranial cavernous angioma: a practical review of clinical and biological aspects. Surg. Neurol.63(4), 319–328; discussion 328 (2005).
  • Sindou M (Ed.). Practical Handbook of Neurosurgery: From Leading Neurosurgeons. Springer-Verlag, Berlin, Germany (2009).
  • Di Rocco C, Iannelli A, Tamburrini G. Cavernomas of the central nervous system in children. A report of 22 cases. Acta Neurochir. (Wien)138(11), 1267–1274; discussion 1273–1264 (1996).
  • Del Curling O Jr, Kelly DL Jr, Elster AD, Craven TE. An analysis of the natural history of cavernous angiomas. J. Neurosurg.75(5), 702–708 (1991).
  • Rocamora R, Mader I, Zentner J, Schulze-Bonhage A. Epilepsy surgery in patients with multiple cerebral cavernous malformations. Seizure18(4), 241–245 (2009).
  • Frischer JM, Pipp I, Stavrou I, Trattnig S, Hainfellner JA, Knosp E. Cerebral cavernous malformations: congruency of histopathological features with the current clinical definition. J. Neurol. Neurosurg. Psychiatry79(7), 783–788 (2008).
  • Williamson A, Patrylo PR, Lee S, Spencer DD. Physiology of human cortical neurons adjacent to cavernous malformations and tumors. Epilepsia44(11), 1413–1419 (2003).
  • Awad I, Jabbour P. Cerebral cavernous malformations and epilepsy. Neurosurg. Focus21(1), e7 (2006).
  • Baumann CR, Schuknecht B, Lo Russo G et al. Seizure outcome after resection of cavernous malformations is better when surrounding hemosiderin-stained brain also is removed. Epilepsia47(3), 563–566 (2006).
  • Kraemer DL, Awad IA. Vascular malformations and epilepsy: clinical considerations and basic mechanisms. Epilepsia35(Suppl. 6), S30–S43 (1994).
  • Brown RD Jr, Wiebers DO, Forbes G et al. The natural history of unruptured intracranial arteriovenous malformations. J. Neurosurg.68(3), 352–357 (1988).
  • Schauble B, Cascino GD, Pollock BE et al. Seizure outcomes after stereotactic radiosurgery for cerebral arteriovenous malformations. Neurology63(4), 683–687 (2004).
  • Panayiotopoulos CP. The Epilepsies: Seizures, Syndromes and Management. Bladon Medical Publishing, Oxfordshire, UK (2005).
  • Spooner CG, Berkovic SF, Mitchell LA, Wrennall JA, Harvey AS. New-onset temporal lobe epilepsy in children: lesion on MRI predicts poor seizure outcome. Neurology67(12), 2147–2153 (2006).
  • French JA, Williamson PD, Thadani VM et al. Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination. Ann. Neurol.34(6), 774–780 (1993).
  • Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N. Engl. J. Med.345(5), 311–318 (2001).
  • Dupont S, Tanguy ML, Clemenceau S, Adam C, Hazemann P, Baulac M. Long-term prognosis and psychosocial outcomes after surgery for MTLE. Epilepsia47(12), 2115–2124 (2006).
  • Mathern GW, Babb TL, Vickrey BG, Melendez M, Pretorius JK. The clinical–pathogenic mechanisms of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy. Brain118(Pt 1), 105–118 (1995).
  • Park KI, Chu K, Jung KH et al. Role of cortical dysplasia in epileptogenesis following prolonged febrile seizure. Epilepsia51(9), 1809–1819 (2010).
  • Fauser S, Huppertz HJ, Bast T et al. Clinical characteristics in focal cortical dysplasia: a retrospective evaluation in a series of 120 patients. Brain129(Pt 7), 1907–1916 (2006).
  • Kasper BS, Stefan H, Paulus W. Microdysgenesis in mesial temporal lobe epilepsy: a clinicopathological study. Ann. Neurol.54(4), 501–506 (2003).
  • Kanemoto K, Kawasaki J, Miyamoto T, Obayashi H, Nishimura M. Interleukin (IL)1β, IL-1α, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann. Neurol.47(5), 571–574 (2000).
  • Ozkara C, Uzan M, Tanriverdi T et al. Lack of association between IL-1β/α gene polymorphisms and temporal lobe epilepsy with hippocampal sclerosis. Seizure15(5), 288–291 (2006).
  • Crompton DE, Scheffer IE, Taylor I et al. Familial mesial temporal lobe epilepsy: a benign epilepsy syndrome showing complex inheritance. Brain133(11), 3221–3231 (2010).
  • Romanelli MF MJ, Ashkin K, Coben LA. Advanced Alzheimer’s disease is a risk factor for late-onset seizures. Arch. Neurol.47, 847–850 (1990).
  • Förstl H BA, Levy R, Cairns N, Luthert P, Lantos P. Neurologic signs in Alzheimer’s disease. Result of a prospective clinical and neuropathological study. Arch. Neurol.49, 1038–1042 (1992).
  • Palop JJ, Mucke L. Epilepsy and cognitive impairments in Alzheimer disease. Arch. Neurol.66(4), 435–440 (2009).
  • Bernardi S, Scaldaferri N, Vanacore N et al. Seizures in Alzheimer’s disease: a retrospective study of a cohort of outpatients. Epileptic Disord.12(1), 16–21 (2010).
  • Palop JJ, Chin J, Roberson ED et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer’s disease. Neuron55(5), 697–711 (2007).
  • Larner AJ, Doran M. Clinical phenotypic heterogeneity of Alzheimer’s disease associated with mutations of the presenilin-1 gene. J. Neurol.253(2), 139–158 (2006).
  • Cabrejo L, Guyant-Marechal L, Laquerriere A et al. Phenotype associated with APP duplication in five families. Brain129(Pt 11), 2966–2976 (2006).
  • Ponomareva NV, Korovaitseva GI, Rogaev EI. EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease. Neurobiol. Aging29(6), 819–827 (2008).
  • Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer’s disease. Proc. Natl Acad. Sci. USA103(15), 5644–5651 (2006).
  • Bien CG, Granata T, Antozzi C et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain128(Pt 3), 454–471 (2005).
  • Bien CG, Schramm J. Treatment of Rasmussen encephalitis half a century after its initial description: promising prospects and a dilemma. Epilepsy Res.86(2–3), 101–112 (2009).
  • Choi J, Koh S. Role of brain inflammation in epileptogenesis. Yonsei Med. J.49(1), 1–18 (2008).
  • Cimaz R, Meroni PL, Shoenfeld Y. Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome). Lupus15(4), 191–197 (2006).
  • Aykutlu E, Baykan B, Serdaroglu P, Gokyigit A, Akman-Demir G. Epileptic seizures in Behcet disease. Epilepsia43(8), 832–835 (2002).
  • Joseph FG, Scolding NJ. Neuro-Behcet’s disease in Caucasians: a study of 22 patients. Eur. J. Neurol.14(2), 174–180 (2007).
  • Chroni E, Monastirli A, Polychronopoulos P et al. Epileptic seizures as the sole manifestation of neuro-Behcet’s disease: complete control under interferon-α treatment. Seizure17(8), 744–747 (2008).
  • Watemberg N, Greenstein D, Levine A. Encephalopathy associated with Hashimoto thyroiditis: pediatric perspective. J. Child Neurol.21(1), 1–5 (2006).
  • Palace J, Lang B. Epilepsy: an autoimmune disease?. J. Neurol. Neurosurg. Psychiatry69(6), 711–714 (2000).
  • Anderson NE, Barber PA. Limbic encephalitis – a review. J. Clin. Neurosci.15(9), 961–971 (2008).
  • McIntosh AM, McMahon J, Dibbens LM et al. Effects of vaccination on onset and outcome of Dravet syndrome: a retrospective study. Lancet Neurol.9(6), 592–598 (2010).
  • Berkovic SF, Harkin L, McMahon JM et al. De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study. Lancet Neurol.5(6), 488–492 (2006).
  • Catenoix H, Marignier R, Ritleng C et al. Multiple sclerosis and epileptic seizures. Mult. Scler.17(1), 96–102 (2011).
  • Banwell B, Shroff M, Ness JM, Jeffery D, Schwid S, Weinstock-Guttman B. MRI features of pediatric multiple sclerosis. Neurology68(16 Suppl. 2), S46–S53 (2007).
  • Olafsson E, Benedikz J, Hauser WA. Risk of epilepsy in patients with multiple sclerosis: a population-based study in Iceland. Epilepsia40(6), 745–747 (1999).
  • Kinnunen E, Wikstrom J. Prevalence and prognosis of epilepsy in patients with multiple sclerosis. Epilepsia27(6), 729–733 (1986).
  • Moreau T, Sochurkova D, Lemesle M et al. Epilepsy in patients with multiple sclerosis: radiological–clinical correlations. Epilepsia39(8), 893–896 (1998).
  • Truyen L, Barkhof F, Frequin ST et al. Magnetic resonance imaging of epilepsy in multiple sclerosis: a case control study. Implications for treatment trials with 4-aminopyridine. Mult. Scler.1(4), 213–217 (1996).
  • Lionetti E, Francavilla R, Pavone P et al. The neurology of coeliac disease in childhood: what is the evidence? A systematic review and meta-analysis. Dev. Med. Child. Neurol.52(8), 700–707 (2010).
  • Giordano L, Valotti M, Bosetti A, Accorsi P, Caimi L, Imberti L. Celiac disease-related antibodies in Italian children with epilepsy. Pediatr. Neurol.41(1), 34–36 (2009).
  • Samokhvalov AV, Irving H, Mohapatra S, Rehm J. Alcohol consumption, unprovoked seizures, and epilepsy: a systematic review and meta-analysis. Epilepsia, (2010).
  • Bartolomei F. Epilepsy and alcohol. Epileptic Disord.8(S1), S72–S78 (2006).
  • Ng SK, Hauser WA, Brust JC, Susser M. Alcohol consumption and withdrawal in new-onset seizures. N. Engl. J. Med.319(11), 666–673 (1988).
  • Rogawski MA. Update on the neurobiology of alcohol withdrawal seizures. Epilepsy Curr.5(6), 225–230 (2005).
  • Mucha RF, Pinel JP. Increased susceptibility to kindled seizures in rats following a single injection of alcohol. J. Stud. Alcohol40(3), 258–271 (1979).
  • Tsai G, Coyle JT. The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu. Rev. Med.49, 173–184 (1998).
  • Rehm J, Baliunas D, Borges GL et al. The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction105(5), 817–843 (2010).
  • Fujiwara T, Shigematsu H. Etiologic factors and clinical features of symptomatic epilepsy: focus on pediatric cases. Psychiatry Clin. Neurosci.58(3), S9-S12 (2004).
  • Guerrini R, Marini C. Genetic malformations of cortical development. Exp. Brain Res.173(2), 322–333 (2006).
  • Chassoux F, Landre E, Rodrigo S et al. Intralesional recordings and epileptogenic zone in focal polymicrogyria. Epilepsia49(1), 51–64 (2008).
  • Kral T, von Lehe M, Podlogar M et al. Focal cortical dysplasia: long term seizure outcome after surgical treatment. J. Neurol. Neurosurg. Psychiatry78(8), 853–856 (2007).
  • Phi JH, Cho BK, Wang KC et al. Longitudinal analyses of the surgical outcomes of pediatric epilepsy patients with focal cortical dysplasia. J. Neurosurg. Pediatr.6(1), 49–56 (2010).
  • Cross JH. Neurocutaneous syndromes and epilepsy-issues in diagnosis and management. Epilepsia46(Suppl. 10), 17–23 (2005).
  • Devlin L, Shepherd CH, Crawford H, Morrison PJ. Tuberous sclerosis complex: clinical features, diagnosis, and prevalence within Northern Ireland. Dev. Med. Child Neurol.48, 495–499 (2006).
  • Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet372(9639), 657–668 (2008).
  • Talos DM, Kwiatkowski DJ, Cordero K, Black PM, Jensen FE. Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers. Ann.Neurol.63(4), 454–465 (2008).
  • Valencia I, Legido A, Yelin K, Khurana D, Kothare SV, Katsetos CD. Anomalous inhibitory circuits in cortical tubers of human tuberous sclerosis complex associated with refractory epilepsy: aberrant expression of parvalbumin and calbindin-D28k in dysplastic cortex. J. Child Neurol.21(12), 1058–1063 (2006).
  • Vivarelli R, Grosso S, Calabrese F et al. Epilepsy in neurofibromatosis 1. J. Child Neurol.18(5), 338–342 (2003).
  • Kulkantrakorn K, Geller TJ. Seizures in neurofibromatosis 1. Pediatr. Neurol.19(5), 347–350 (1998).
  • Rosenfeld A, Listernick R, Charrow J, Goldman S. Neurofibromatosis type 1 and high-grade tumors of the central nervous system. Childs Nerv. Syst.26(5), 663–667 (2010).
  • Jensen FE. Developmental factors regulating susceptibility to perinatal brain injury and seizures. Curr. Opin. Pediatr.18(6), 628–633 (2006).
  • Badawi N, Felix JF, Kurinczuk JJ et al. Cerebral palsy following term newborn encephalopathy: a population-based study. Dev. Med. Child Neurol.47(5), 293–298 (2005).
  • Lynch JK. Epidemiology and classification of perinatal stroke. Semin. Fetal Neonatal Med.14(5), 245–249 (2009).
  • Golomb MR, Garg BP, Carvalho KS, Johnson CS, Williams LS. Perinatal stroke and the risk of developing childhood epilepsy. J. Pediatr.151(4), 409–413, 413 e401–402 (2007).
  • Sun Y, Vestergaard M, Pedersen CB, Christensen J, Basso O, Olsen J. Gestational age, birth weight, intrauterine growth, and the risk of epilepsy. Am. J. Epidemiol.167(3), 262–270 (2008).
  • Sun Y, Vestergaard M, Pedersen CB, Christensen J, Olsen J. Apgar scores and long-term risk of epilepsy. Epidemiology17(3), 296–301 (2006).
  • Ehrenstein V, Pedersen L, Holsteen V, Larsen H, Rothman KJ, Sorensen HT. Postterm delivery and risk for epilepsy in childhood. Pediatrics119(3), e554–561 (2007).
  • Rakhade SN, Jensen FE. Epileptogenesis in the immature brain: emerging mechanisms. Nat. Rev. Neurol.5(7), 380–391 (2009).
  • Dzhala VI, Talos DM, Sdrulla DA et al. NKCC1 transporter facilitates seizures in the developing brain. Nat. Med.11(11), 1205–1213 (2005).
  • Pagon RA, Bird TD, Dolen CR et al. Gene Reviews. University of Washington, Seattle, WA, USA (1993).
  • Bahi-Buisson KM, Léger PL, Valayanopoulos V et al. [Neonatal epilepsy and inborn errors of metabolism]. Archives Pédiatrie13(3), 284–292 (2006).
  • Genton P, Malafosse A, Moulard B et al. (Eds). Progressive Myoclonus Epilepsies. John Libbey Eurotext, Paris, France (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.